VAL158MET catechol O-methyltransferase polymorphism contributes to the development of preeclampsia

References

• Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.
   PubMed Web of Science ®Google Scholar
• Mayrink J, Souza RT, Feitosa FE, et al. Incidence and risk factors for Preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control study. Sci Rep. 2019;9(1):9517.
   PubMedGoogle Scholar
• Roberts J, Hubel C. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(SupplA):S32–7.
   PubMedGoogle Scholar
• Nelissen EC, van Montfoort AP, Dumoulin JC, et al. Epigenetics and the placenta. Hum Reprod Update. 2011;17(3):397–417.
   PubMed Web of Science ®Google Scholar
• LaMarca BD, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension. 2008;51(4):982–988.
   PubMed Web of Science ®Google Scholar
• Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1972;1:177–191.
   PubMedGoogle Scholar
• Berg D, Sonsalla R, Kuss E. Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labelled ligand. Acta Endocrinol (Copenh). 1983;103: 282–288.
   PubMedGoogle Scholar
• Lee SB, Wong AP, Kanasaki K, et al. Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol. 2010;176:710–720.
   PubMed Web of Science ®Google Scholar
• Mabjeesh NJ, Escuin D, LaVallee TM, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 2003;3:363–375.
   PubMed Web of Science ®Google Scholar
• Chen J, Lipska BK, Halim N, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004;75:807–821.
   PubMed Web of Science ®Google Scholar
• Rutherford K, Alphandéry E, McMillan A, et al. The V108M mutation decreases the structural stability of catechol O-methyltransferase. Biochemi Biophys Acta. 2008;1784:1098–1105.
   PubMed Web of Science ®Google Scholar
• Kanasaki K, Palmsten K, Sugimoto H, et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature. 2008;453(7198):1117–1121.
   PubMed Web of Science ®Google Scholar
• Liang S, Liu X, Fan P, et al. Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population. Arch Med Res. 2012;43(2):154–158.
   PubMed Web of Science ®Google Scholar
• Lim JH, Kim SY, Kim DJ, et al. Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17 in preeclampsia. Pharmacogenet Genomics. 2010;20:605e610.
   Web of Science ®Google Scholar
• Roten LT, Fenstad MH, Forsmo S, et al. A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod. 2011;17:439e446.
   Web of Science ®Google Scholar
• Hill LD, York TP, Kusanovic JP, et al. Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PLoS One. 2011;6(1):e16681.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu J, Zhao C, et al. Association between COMT Val158Met polymorphism and preeclampsia in the Chinese Han population. Hypertens Pregnancy. 2016;35(4):565–572.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534–543.
   PubMed Web of Science ®Google Scholar
• Freeman DJ, McManus F, Brown EA, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension. 2004;44(5):708–714.
   PubMed Web of Science ®Google Scholar
• LaMarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology. 2013;28(4):225–233.
   PubMed Web of Science ®Google Scholar
• Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract. 2013;22(Suppl 1):8–19.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122‐31.
   Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Sljivancanin Jakovljevic T, Kontic-Vucinic O, Nikolic N, et al. Glutathione-S-transferase M1 polymorphism and pro-inflammatory cytokines tumour necrosis factor-α and interleukin-1β are associated with preeclampsia in Serbian women. Am J Reprod Immunol. 2019;81(5):e13105.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real‐time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25(4):402‐8.
   PubMed Web of Science ®Google Scholar
• Zhu BT, Wu KY, Wang P, et al. O-methylation of catechol estrogens by human placental catechol- o-methyltransferase: interindividual differences in sensitivity to heat inactivation and to inhibition by dietary polyphenols. Drug Metab Dispos. 2010;38:1892–1899.
   PubMed Web of Science ®Google Scholar
• Zhu BT. Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab. 2002;3:321–349.
   PubMed Web of Science ®Google Scholar
• Pertegal M, Fenoy FJ, Hernández M, et al. Fetal Val108/158Met catechol-O-methyltransferase (COMT) polymorphism and placental COMT activity are associated with the development of preeclampsia. Fertil Steril. 2016;105(1):134–43.e433.
   PubMed Web of Science ®Google Scholar
• Ueki N, Kanasaki K, Kanasaki M, et al. Catechol-O-methyltransferase deficiency leads to hypersensitivity of the pressor response against angiotensin II. Hypertension. 2017;69(6):1156–1164.
   PubMed Web of Science ®Google Scholar
• Parchem JG, Kanasaki K, Kanasaki M, et al. Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice. J Clin Invest. 2018;128(11):5008–5017.
   PubMed Web of Science ®Google Scholar
• Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51:593–628.
   PubMed Web of Science ®Google Scholar
• Hall KT, Nelson CP, Davis RB, et al. Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014;34(9):2160–2167.
   PubMed Web of Science ®Google Scholar
• Hagen K, Pettersen E, Stovner LJ, et al. High systolic blood pressure is associated with Val/Val genotype in the catechol-O-methyltransferase gene. The Nord-Trøndelag Health Study (HUNT). Am J Hypertens. 2007;20:21–26.
   PubMed Web of Science ®Google Scholar
• Annerbrink K, Westberg L, Nilsson S, et al. Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metabolism. 2008;57:708–711.
   PubMed Web of Science ®Google Scholar
• Kamide K, Kokubo Y, Yang J, et al. Association of genetic polymorphisms of ACADSB and COMT with human hypertension. J Hypertens. 2007;25:103–110.
   PubMed Web of Science ®Google Scholar
• Barnea ER, MacLusky NJ, DeCherney AH, et al. Catechol-O-methyltransferase activity in the human term placenta. Am J Perinatol. 1988;5:121–127.
   PubMed Web of Science ®Google Scholar
• Pérez-Sepúlveda A, Torres MJ, Valenzuela FJ, et al. Low 2-methoxyestradiol levels at the first trimester of pregnancy are associated with the development of pre-eclampsia. Prenat Diagn. 2012;32(11):1053–1058.
   PubMed Web of Science ®Google Scholar
• Taravati A, Tohidi F, Moniri M, et al. Catechol-O-methyltransferase gene polymorphism (Val158Met) and development of pre-eclampsia. Arch Med Res. 2017;48(2):180–186.
   PubMed Web of Science ®Google Scholar
• Krnjeta T, Mirkovic L, Ignjatovic S, et al. Protective role of maternal p.val158met catechol-o-methyltransferase polymorphism against early-onset preeclampsia and its complications. J Med Biochem. 2016;35:312–318.
   PubMed Web of Science ®Google Scholar
• Caughey AB, Stotland NE, Washington AE, et al. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol. 2005;106:156–161.
   PubMed Web of Science ®Google Scholar
• Hartung JE, Ciszek BP, Nackley AG. β2- and β3-adrenergic receptors drive COMT-dependent pain by increasing production of nitric oxide and cytokines. Pain. 2014;155(7):1346–1355.
   PubMed Web of Science ®Google Scholar
• Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab. 2007;18:365–370.
   PubMed Web of Science ®Google Scholar
• Sata F, Yamada H, Suzuki K, et al. Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction. Pharmacogenet Genomics. 2006;16:775–781.
   PubMed Web of Science ®Google Scholar
• Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 1996;36:203–232.
   PubMed Web of Science ®Google Scholar
• Malins DC, Holmes EH, Polissar NL, et al. The etiology of breast cancer: characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer. 1993;71:3036–3043.
   PubMed Web of Science ®Google Scholar
• Malins DC, Polissar NL, Gunselman SJ. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc Natl Acad Sci USA. 1996;93:2557–2563.
   PubMed Web of Science ®Google Scholar
• Scholl TO, Stein TP. Oxidant damage to DNA and pregnancy outcome. J Matern Fetal Med. 2001;10:182–185.
   PubMedGoogle Scholar